Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,370.00
(
-0.75%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
104.01
(
-0.39%
)
Bitcoin
76,957.92
(
0.80%
)
News Focus
News Focus
Post# of 17817
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Watsonturtle

Send PM Follow Ignore
Followers 4
Posts 129
Boards Moderated 0
Alias Born 05/11/2016

Watsonturtle

Re: Whalatane post# 17217

Tuesday, 12/19/2023 2:53:10 PM

Tuesday, December 19, 2023 2:53:10 PM

Post# of 17817
A lot of good news appears to be building up for Auph:
(a) NVS terminates LN trial, (b) Eular recommendations and guidelines, (c) treatment period per Eular guidelines trending to 3 years, (c) some apparently seeing Medicare issuing very liberal approvals for use of VOC treatment protocol (per Lorddragon on X), (d) Otsuka EU sales appear to be strong ... appears to have added 3K to 5K patients in only its second Q of sales in EU (per derived by Lorddragon on X from Otsuka's royalty payments to Auph). WT
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AUPH News
More AUPH News